Myriad Genetics Enters Oversold Territory

Myriad Genetics, Inc.’s (NasdaqGS:MYGN - News) share price has entered into oversold territory with a stochastic value of 17.588. The Zacks Consensus Estimate on the company’s earnings for June 2012 increased by 2 cents over the past month to $1.26 per share. Myriad Genetics is a Zacks #2 Rank (“Buy”) company.

MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report

Zacks Investment Research

• Read the analyst report on MYGN